Table 1

Characteristics of participants in the NHL nested case-control study

CharacteristicCases (n = 271)Controls (n = 538)P*
Mean age at blood draw, y (SD) 70.0 (7.4) 70.0 (7.5)  
Hours fasting before blood draw, mean (SD) 12.0 (4.0) 12.3 (4.1)  
Male, n (%) 157 (57.9) 312 (58.0)  
Ethnicity, n (%)    
    Black 46 (17.0) 92 (17.1)  
    Native Hawaiian 17 (6.3) 33 (6.1)  
    Japanese American 72 (26.6) 142 (26.4)  
    Latino 62 (22.9) 123 (22.9)  
    White 74 (27.3) 148 (27.5)  
Years of education, mean (SD) 13.7 (3.0) 13.7 (3.2) .88 
Mean BMI, kg/m2 (SD) 26.9 (5.3) 26.4 (4.3) .16 
Pack-years of cigarette smoking, mean (SD) 10.5 (15.1) 9.8 (15.2) .54 
Mean physical activity, h/d (SD) 1.2 (1.2) 1.3 (1.4) .29 
Mean alcohol intake, g/d (SD) 9.7 (24.4) 11.2 (28.4) .43 
Positive history of blood transfusion, n (%) 23 (8.5) 53 (9.9) .53 
NHL subtype, n (%)    
    DLBCL 78 (28.8)   
    Follicular lymphoma 49 (18.1)   
    T-cell lymphomas 15 (5.5)   
    SLL/CLL 51 (18.8)   
    Other types 78 (28.8)   
Total carotenoids, ng/mL 1184 (862-1659) 1326 (965-1769) .02 
    α-carotene, ng/mL 48 (29-81) 54 (32-83) .20 
    β-carotene, ng/mL 224 (118-440) 264 (147-430) .08 
    Lycopene, ng/mL 370 (275-521) 439 (320-583) < .01 
    Dihydrolycopene, ng/mL 93 (67-127) 107 (79-138) < .01 
    trans-lutein, ng/mL 96 (73-129) 104 (78-138) .09 
    α-cryptoxanthin, ng/mL 30 (22-41) 33 (26-43) < .01 
    β-cryptoxanthin, ng/mL 156 (103-270) 168 (106-295) .45 
    trans-zeaxanthin, ng/mL 20 (16-26) 20 (16-26) .87 
Retinol, ng/mL 648 (527-798) 661 (562-780) .19 
CharacteristicCases (n = 271)Controls (n = 538)P*
Mean age at blood draw, y (SD) 70.0 (7.4) 70.0 (7.5)  
Hours fasting before blood draw, mean (SD) 12.0 (4.0) 12.3 (4.1)  
Male, n (%) 157 (57.9) 312 (58.0)  
Ethnicity, n (%)    
    Black 46 (17.0) 92 (17.1)  
    Native Hawaiian 17 (6.3) 33 (6.1)  
    Japanese American 72 (26.6) 142 (26.4)  
    Latino 62 (22.9) 123 (22.9)  
    White 74 (27.3) 148 (27.5)  
Years of education, mean (SD) 13.7 (3.0) 13.7 (3.2) .88 
Mean BMI, kg/m2 (SD) 26.9 (5.3) 26.4 (4.3) .16 
Pack-years of cigarette smoking, mean (SD) 10.5 (15.1) 9.8 (15.2) .54 
Mean physical activity, h/d (SD) 1.2 (1.2) 1.3 (1.4) .29 
Mean alcohol intake, g/d (SD) 9.7 (24.4) 11.2 (28.4) .43 
Positive history of blood transfusion, n (%) 23 (8.5) 53 (9.9) .53 
NHL subtype, n (%)    
    DLBCL 78 (28.8)   
    Follicular lymphoma 49 (18.1)   
    T-cell lymphomas 15 (5.5)   
    SLL/CLL 51 (18.8)   
    Other types 78 (28.8)   
Total carotenoids, ng/mL 1184 (862-1659) 1326 (965-1769) .02 
    α-carotene, ng/mL 48 (29-81) 54 (32-83) .20 
    β-carotene, ng/mL 224 (118-440) 264 (147-430) .08 
    Lycopene, ng/mL 370 (275-521) 439 (320-583) < .01 
    Dihydrolycopene, ng/mL 93 (67-127) 107 (79-138) < .01 
    trans-lutein, ng/mL 96 (73-129) 104 (78-138) .09 
    α-cryptoxanthin, ng/mL 30 (22-41) 33 (26-43) < .01 
    β-cryptoxanthin, ng/mL 156 (103-270) 168 (106-295) .45 
    trans-zeaxanthin, ng/mL 20 (16-26) 20 (16-26) .87 
Retinol, ng/mL 648 (527-798) 661 (562-780) .19 

DLBCL indicates diffuse large B-cell lymphoma; and SLL/CLL, small lymphocytic lymphoma/chronic lymphocytic lymphoma.

*

P values obtained by χ2 test for categorical variables; t tests were performed for all continuous variables except for the non-normally distributed carotenoids, for which a nonparametric Wilcoxon rank-sum test was used.

Matching variable; cases and controls were matched on sex, birth year (± 1 year), location (Hawaii or California), ethnicity, date of blood draw (± 1 year), time of blood draw (± 2 hours), and hours fasting before blood draw (< 6, 6 to < 8, 8 to < 10, ≥ 10).

Medians and 25th-75th percentiles are presented for carotenoids and retinol.

Close Modal

or Create an Account

Close Modal
Close Modal